很抱歉,您的瀏覽器過於老舊無法閱讀網頁內容的需要,請更新瀏覽器或安裝 Google Chrome.

Investor Relations

Announcement

The Company received notice from PMCC to terminate clinical trial of Pidnarulex with Pfizer PARP inhibitor.

The Company received notice from PMCC to terminate clinical trial of Pidnarulex with Pfizer PARP inhibitor.

Apr
11
2025

Event

Notice of the 2025 Annual Shareholders’ Meeting

Notice of the 2025 Annual Shareholders’ Meeting

Meeting Title: 2025 Annual Shareholders’ Meeting
Date and Time: Wednesday, June 25, 2025, at 10:00 AM (Check-in starts at 9:30 AM)
Venue: Conference Room, 2nd Floor, No. 223, Section 3, Beixin Road, Xindian District, New Taipei City (International Conference Center)

Jun
24
2025